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Background: Questionnaires may help in detecting and diagnosing anxiety disorders in primary care. However,
since utility of these questionnaires in target populations is rarely studied, the Patient Health Questionnaire anxiety
modules (PHQ) were evaluated for use as: a) a screener in high-risk patients, and/or b) a case finder for general
practitioners (GPs) to assist in diagnosing anxiety disorders.
Methods: A cross-sectional analysis was performed in 43 primary care practices in the Netherlands. The added
value of the PHQ was assessed in two samples: 1) 170 patients at risk of anxiety disorders (or developing them)
according to their electronic medical records (high-risk sample); 2) 141 patients identified as a possible ‘anxiety case’
by a GP (GP-identified sample). All patients completed the PHQ and were interviewed using the Mini International
Neuropsychiatric interview to classify DSM-IV anxiety disorders. Psychometric properties were calculated, and a
logistic regression analysis was performed to assess the diagnostic value of the PHQ.
Results: Using only the screening questions of the PHQ, the area under the curve was 83% in the high-risk sample.
In GP-identified patients the official algorithm showed the best characteristics with an area under the curve of 77%.
Positive screening questions significantly increased the odds of an anxiety disorder diagnosis in high-risk patients
(odds ratio = 23.4; 95% confidence interval 6.9 to 78.8) as did a positive algorithm in GP-identified patients
(odds ratio = 13.9; 95% confidence interval 3.8 to 50.6).
Conclusions: The PHQ screening questions can be used to screen for anxiety disorders in high-risk primary care
patients. In GP-identified patients, the benefit of the PHQ is less evident.
Keywords: Anxiety disorder, Patient health questionnaire, Primary care, Screening, Case finding, Criterion validityBackground
In health care systems in which the general practitioner
(GP) acts as the gatekeeper to mental health care, the abi-
lity of GPs to accurately detect and diagnose psychiatric
disorders is crucial. Anxiety disorders are a major category
of the psychiatric disorders encountered in primary care.
The ability of GPs to detect anxiety disorders has often
been criticised [1] as GPs only detect one third to one half
of the patients with an anxiety disorder [2-4]. Although* Correspondence: a.muntingh@ggzingeest.nl
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reproduction in any medium, provided the orGPs do suspect psychological problems in many of these
patients, they do not often classify these problems with a
diagnosis of an anxiety disorder [5]. However, the classi-
fication of an anxiety disorder diagnosis facilitates the
implementation of clinical guidelines, as these include
diagnosis-specific treatments [4,6]. Furthermore, the
provision of multidisciplinary care may be enhanced by
the use of common terms by GPs and mental health
professionals [7,8].
To increase the identification and, ultimately, treat-
ment of patients with anxiety disorders in primary care,
screening is often considered [9]. Screening is intended
to identify individuals at risk of having or developing a
disorder. There are several questionnaires available thatral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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http://www.biomedcentral.com/1471-244X/13/192have been shown to be valid instruments to screen for
anxiety disorders in primary care [10-13]. However,
screening large populations of patients for mental dis-
orders is generally not considered efficient as this requires
a substantial investment and may be of limited effective-
ness in increasing recognition and treatment [14]. We
clearly need a more efficient approach to identify patients
with anxiety disorders who are likely to profit from treat-
ment. It has been proposed to purposefully screen patients
who are at high risk of developing a disorder [15]. Another
approach that has already been suggested in guidelines for
depression [16] and anxiety [17] is to help the GP to dis-
tinguish distress symptoms from an anxiety disorder [18]
by using a screening instrument (case finding). However,
evidence of the value of available screening instruments in
screening high-risk groups (selective screening) and in
assisting GPs in diagnosing an anxiety disorder is limited.
The Patient Health Questionnaire (PHQ) might be
suitable for this purpose because this scale was specifically
designed for use in primary care [13] and has shown
adequate psychometric properties [13,19,20]. The PHQ
consists of different modules about common mental
health disorders, including a module about panic disorder
and one about general anxiety. Earlier studies about the
PHQ anxiety module focused on the validity as a screener
in a random primary care sample [13], different groups of
hospital patients [19-21], the community [22], and in
psychosomatic outpatients [23]. A recent study showed
that the ability of the PHQ panic module to detect panic
disorder in high-risk primary care patients was moderate
[24]. However, most GPs will be interested in the presence
of any anxiety disorder, after which they may decide to
perform extra diagnostic procedures or refer the patient
to a mental health professional.
In conclusion, information about the practical value
of existing screening instruments for anxiety disorders
in primary care is insufficient. We therefore evaluated
the PHQ anxiety modules for use as: a) a screener in
high-risk patients, and/or b) a case finder for general
practitioners to assist in diagnosing anxiety disorders in
a pragmatic diagnostic study.
Method
Participants
Patients were recruited between November 2008 and
March 2010 in 43 primary care practices. Two samples of
patients were studied: 1) primary care patients at risk of
anxiety disorders (or developing them), identified via their
electronic medical record (EMR) (high-risk sample); 2)
patients identified as a possible ‘anxiety case’ by their GP
(GP-identified sample). Except for their entrance into the
study (selection from the EMR or identification by their
GP), patients followed the same procedure. This study
was performed in primary care practices that participatedin a cluster randomised controlled trial (RCT) focusing on
the treatment of panic disorder and generalised anxiety
disorder in primary care [25].
Exclusion criteria
We excluded patients who were suicidal, patients who suf-
fered from dementia or other severe cognitive disorders,
psychotic disorder, bipolar disorder and dependence on
drugs or alcohol. Other exclusion criteria were insufficient
knowledge of the Dutch language to complete the ques-
tionnaire and receiving regular psychological treatment.
Selection of the high-risk sample
To select patients who were at risk of anxiety disorders
(or developing them), electronic medical records (EMRs)
were searched. Of the 43 practices participating in the
RCT, 24 practices agreed to the screening procedure and
made use of an electronic system suitable for selecting
patients from the EMR. Patients were selected from the
EMR if they were over 18 years of age and had visited
their general practitioner in the previous three months
with symptoms that were considered to indicate a high
risk of anxiety disorders. Such symptoms were fatigue,
headache, dizziness, weakness, muscle- and joint pain,
stomach ache, chest pain, hyperventilation, anxiety or
depression (or symptoms thereof ), or social problems
(such as loneliness or marital problems). These symp-
toms have been identified as risk factors for having or
developing anxiety disorders [26-28].
Selection of the GP-identified sample
GPs were asked to identify patients with an anxiety dis-
order (specifically panic disorder and generalised anxiety
disorder). Because the GPs participated in an RCT, they
received instructions to refer patients to the study if they
judged them to have an anxiety disorder. Instructions
were based on the national guidelines for GPs, which are
available to all GPs in the Netherlands. GPs (N = 37)
who were allocated to the intervention group of the
RCT received these instructions during a meeting in
which the RCT was explained. GPs in the control group
(N = 26) of the RCT received an educational folder.
Procedure
Patients who were selected from the EMR (high-risk sample)
and patients who were identified by their GP (GP-identified
sample) received a letter informing them about the RCT, to-
gether with an informed consent form and the Patient
Health Questionnaire (PHQ) anxiety module. The patients
were asked to return the PHQ and the informed consent
form directly to the researcher. They were not informed
about the allocation of their GP in the RCT. Patients who
gave informed consent were contacted by telephone by a re-
search assistant to perform a diagnostic interview.
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Screener
The PHQ anxiety modules [13] consist of 22 questions
concerning anxiety symptoms experienced during the
previous four weeks. The first 15 questions screen for a
panic disorder, starting with four questions about the
presence of panic attacks and anxiety (first screening
question: “In the last 4 weeks, have you had an anxiety
attack – suddenly feeling fear or panic?”) and subse-
quently asking about symptoms of panic attacks, such
as “Were you short of breath?”. The second part of the
PHQ consists of seven characteristics of generalised an-
xiety, starting with a screening question “Feeling nervous,
anxious, on edge, or worrying a lot about different things”,
followed by symptoms of generalised anxiety. The respon-
dents are asked to indicate how often they were bothered
by these problems (“not at all”, “several days” or “more
than half the days”). Good overall accuracy has been
reported for both subscales [13,19,23] and a good test-
retest reliability (Kappa 0.84) of the PHQ panic module
has been reported in chronic Hepatitis C patients [29].
Both modules are scored using an algorithm which leads
to a conclusion about the likely presence (positive algo-
rithm) or absence (negative algorithm) of the anxiety dis-
order. If the first four questions of the panic module were
answered affirmatively, and at least four symptoms of
panic attacks were present, this was counted as a positive
algorithm [13]. If the first question of the generalised an-
xiety module was answered with “more than half the days”
and at least three symptoms of generalised anxiety were
present for more than half the days, this was also counted
as a positive algorithm [13]. If a negative algorithm was
scored on both modules, this was counted as a negative al-
gorithm. We also tested the diagnostic validity of the two
screening questions, since the use of this simplified algo-
rithm may be more suitable for high-risk groups [24] and
is more useful in busy general practices. An affirmative
answer to the first screening question of the panic module
or the answer “more than half the days” to the screening
question of the generalised anxiety module was consi-
dered as positive screening questions.
Reference standard
The Mini International Neuropsychiatric interview
(MINI-PLUS) was used as a reference standard and
to assess exclusion criteria. MINI-PLUS is a short struc-
tured diagnostic interview that is used to determine the
most common DSM-IV [30] and ICD-10 [31] psychiatric
disorders [32] (Dutch version [33]). The following anxiety
disorders were classified: panic disorder (PD) with or
without agoraphobia, generalised anxiety disorder (GAD),
social phobia, simple phobia, obsessive compulsive dis-
order, post-traumatic stress disorder and agoraphobia
(without panic disorder). Depressive disorders, suicidalideation, psychotic disorders and substance use disorders
were also assessed using the MINI-PLUS. The inter-
viewers who conducted the MINI interviews by telephone
had a medical or psychological background, with degrees
varying from bachelor to master. They received training in
how to carry out the MINI interview and were supervised
by a psychologist and a psychiatrist. At least two interviews
carried out by each interviewer were audio-taped and eval-
uated by the psychologist. The interviewers had the oppor-
tunity to verify their diagnosis with a study psychiatrist. All
interviewers and the study psychiatrist were blinded for
the PHQ score to prevent confirmation bias.
Recruitment
High-risk sample
The PHQ was sent to 2,408 patients who were at risk of
developing an anxiety disorder according to the informa-
tion in their EMR. A total of 786 (32.6%) patients com-
pleted and returned the questionnaire (Figure 1). The
proportion of females did not differ significantly between
responders and non-responders (70% versus 69%, p >
0.05) but the responders were slightly older than the non-
responders (51.9 versus 48.3 years, p < .05). All patients
with a positive algorithm (N = 150), and a random selec-
tion of 57 patients with a negative algorithm were invited
for a MINI interview. After the exclusion of patients who
met exclusion criteria (N = 13, 8.7% positive algorithm, N
= 1, 2% negative algorithm), and due to non-response (N
= 16, 10.7% positive algorithm, N = 7, 10.5% negative algo-
rithm), 121 participants with a positive algorithm and 49
participants with a negative algorithm had a MINI inter-
view (n = 170). Figure 1 presents a flowchart of the high-
risk sample.
GP-identified sample
GPs of 37 practices selected 207 patients for the study.
All patients who gave informed consent and who did
not meet the exclusion criteria (N = 164, 79.2%) were in-
vited for a MINI interview, irrespective of their PHQ
score, and eventually 141 patients were interviewed.
As we found no significant difference in the diagnostic
accuracy of GPs randomised to the intervention or con-
trol group of the RCT (data not shown), we analysed the
total group of patients identified by their GP. Figure 2
presents a flowchart of patients identified by their GP.
Data analysis
In the high-risk sample, we had to correct for the fact
that we included a random sample of patients with a
negative algorithm, while we did include all patients with
a positive algorithm. Such a selection procedure creates
an imbalance that influences the prevalence and thus the
test characteristics. Weights were used to transform the
sample back to the original distribution of positive and
Figure 2 Flowchart of patients identified as a case by GPs (GP-identified sample).
Figure 1 Flowchart of participants at risk of an anxiety disorder (or of developing one) according to their electronic medical record
(high-risk sample).
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received a weight of 0.27 (150/121*170/786) and a nega-
tive algorithm patient received a weight of 2.81 (636/
49*170/786). A similar procedure was followed for the
analysis in the high-risk sample using the two screening
questions. All psychometric analyses concerning the
high-risk group were performed on the weighted sample.
The following indicators of criterion validity were calcu-
lated: positive predictive value, negative predictive value,
sensitivity, specificity, overall accuracy and receiver oper-
ating characteristics (area under the curve, AUC) [35].
The MINI classification functioned as reference standard
for the diagnosis of an anxiety disorder. A multilevel
logistic regression analysis was performed to determine
whether a positive algorithm or positive screening ques-
tions increased the odds of a MINI anxiety disorder clas-
sification. SPSS version 15.0 was used for the majority of
the statistical analyses; MLwiN V2 2.21 [36] was used
for the multilevel logistic regression analysis.
Results
Participants
In the weighted high-risk sample (N = 170) the mean age
was 54.6 (SD 13.2), the percentage of females was 74%
and the prevalence of any anxiety disorder was 39%. In
the GP-identified sample (N = 141), the mean age was
47.5 (SD 16.4), the percentage of females was 71% and the
prevalence of any anxiety disorder was 80% (Table 1).
Test results
The results are summarised in Table 2. For the high-risk
sample, the two screening questions of the PHQ showed
the best test characteristics, due to an increase in sensiti-
vity. The positive predictive value (PPV) was 76%, the
negative predictive value (NPV) was 88% and the overallTable 1 Characteristics of the high-risk sample (weighted) an
1) High-risk samp
N (%)
Mean age (range) 54.6 (19–82)
Female 124 (74.4%)
Male 43 (25.2%)
Anxiety disorder diagnosis* 67 (39.4%)
Panic disorder 23 (13.5%)
Generalised anxiety disorder 23 (13.5%)
Social phobia 17 (10.1%)
Simple phobia 11 (6.7%)
Obsessive compulsive disorder 2 (0.9%)
Post-traumatic stress disorder 1 (0.3%)
Agoraphobia 19 (11.0%)
Major depressive disorder 11 (6.5%)
*Percentages do not total to 100% since many patients had more than one anxietyperformance of the PHQ as expressed by the area under
the curve was 83%, which may be interpreted as moderate
to high [35]. In GP-identified patients, the official algo-
rithm performed best, with a PPV of 96%, an NPV of 38%
and the area under the curve was moderate (77%).
Diagnostic value of the PHQ
In the high-risk sample, a positive algorithm significantly
increased the odds of a MINI anxiety disorder classifica-
tion (odds ratio 6.7; 95% confidence interval (CI) 3.0-14.6)
and positive screening questions even more so (odds ratio
23.4; 95% CI 6.9-78.8). In the GP-identified patients, a
positive algorithm significantly increased the odds of a
MINI classification (odds ratio 13.8; 95% CI 3.8-50.6) as
did positive screening questions, although to a lesser
extent (odds ratio 7.3; 95% CI 2.1 – 25.7).
Discussion
Summary of main findings
The results imply that the PHQ screening questions may
be used to screen for anxiety disorders in high-risk
groups. The official algorithm may be useful as an ad-
junct to the clinical diagnosis made by the GP. In the
high-risk sample, the performance of the PHQ using the
official algorithm was moderate, but the two screening
questions of the PHQ showed good test characteristics. In
the GP-identified sample, a positive algorithm adequately
predicted the presence of an anxiety disorder but the ability
of the PHQ to filter out non-cases was inadequate in these
patients.
Strengths and limitations of the study
A strength of this study is its focus on the practical
purpose of screening and case finding.d the GP-identified sample














Table 2 Psychometric properties of the PHQ disorder in a high-risk sample (weighted) and a GP-identified sample
High-risk sample (N = 170) GP-identified sample (N = 141)
Official algorithma Screening questionsb Official algorithma Screening questionsb
Cross-tabulation a b c d a b c d a b c d a b c d
25 8 42 95 49 15 12 93 73 3 40 25 106 21 7 7
Prevalence 0.39 (67/170) 0.36 (61/170) 0.80 (113/141) 0.80 (113/141)
Positive predictive value 0.77 (25/32) 0.76 (49/64) 0.96 (73/76) 0.84 (106/127)
[0.71–0.83] [0.70–0.83] [0.93–0.99] [0.77–0.90]
Negative predictive value 0.69 (95/138) 0.88 (93/105) 0.38 (25/65) 0.50 (7/14)
[0.62–0.76] [0.83–0.93] [0.30–0.46] [0.42–0.58]
Positive likelihood ratio 5.1 [4.41–5.79] 5.71 [4.93–6.49] 6.03 [5.12–6.94] 1.25 [1.16–1.35]
Negative likelihood ratio 0.68 [0.61–0.75] 0.23 [0.17–0.30] 0.40 [0.32–0.48] 0.25 [0.18–0.32]
Sensitivity 0.37 (25/67) 0.80 (49/61) 0.65 (73/113) 0.94 (106/113)
[0.30–0.44] [0.74–0.86] [0.57–0.72] [0.90–0.98]
Specificity 0.93 (95/103) 0.86 (93/108) 0.89 (25/28) 0.25 (7/28)
[0.89–0.97] [0.81–0.91] [0.84–0.94] [0.18–0.32]
Overall accuracy 0.71 (95 + 25/170) 0.84 (93 + 49/170) 0.70 (73 + 25/141) 0.80 (106 + 7/141)
[0.64–0.78] [0.78–0.89] [0.62–0.77] [0.74–0.87]
Area under the curve 0.65* 0.83* 0.77 [0.68–0.86] 0.60 [0.47–0.72]
[0.64–0.66] [0.82–0.84]
a: true positives, b: false positives, c: false negatives, d: true negatives, a Official algorithm panic disorder: All the first four questions were answered with “yes” and
four symptoms related to panic attacks are present. Official algorithm general anxiety: The first question was answered with “more than half the days” and three
symptoms related to general anxiety were present more than half the days. b Screening question for panic disorder (“In the last 4 weeks, have you had an anxiety
attack - suddenly feeling fear or panic?”) was answered with yes AND/OR screening question for general anxiety (“Feeling nervous, anxious, on edge, or worrying
a lot about different things”) was answered with “more than half the days”. *Because weighting in the receiver operating characteristics (ROC) analysis is only
possible with integer values, the weights were multiplied by 100).
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care practices that participated in an RCT. However, ex-
clusion criteria from the RCT do not seem to have had a
significant influence on the results, as only 29 out of 951
patients (3%) who returned the PHQ were eventually
excluded based on the exclusion criteria of the RCT. Our
population was clearly broader than the population of the
RCT; eventually, 180 (58%) out of 311 patients par-
ticipated in the RCT. Another limitation was the low
response rate in the high-risk sample. Patients who expe-
rienced anxiety problems may have been more likely to re-
turn the questionnaire and therefore the prevalence of
anxiety disorders in our study may be overestimated.
However, a similar response pattern may also be expected
if a screening procedure were to be conducted in daily
practice and therefore is also consistent with our aim of
assessing the practical value of the PHQ.
Because GPs in our study may have had an increased
interest in anxiety disorders and received instructions on
the recognition of anxiety disorders, they may have had a
greater ability to recognise anxiety disorders than seen in
the total population of GPs. However, instructions were
minimal and based on the national guidelines for GPs
(which are available to all GPs in the Netherlands) and weconsider it unlikely that this has significantly influenced
the skills of the GPs.
Comparison with existing studies
This study confirms that the characteristics of patients
influence test characteristics [37]. It is therefore relevant
to test the value of a questionnaire in different populations
and to relate findings to those of similar studies. The per-
formance of the PHQ in our high-risk sample is consistent
with the performance of the panic module in a previous
study with a high-risk sample consisting of frequent at-
tenders, patients with medically unexplained symptoms,
and patients with mental health problems in primary care
[24]. The authors also found that using only the screening
questions improved the performance of the PHQ substan-
tially and concluded that the PHQ was of moderate value
for screening in high-risk groups. Other studies have
found a better performance of the PHQ [13,19,20]. This
may be due to the characteristics of our study population
(patients at risk of anxiety disorders), with our study
design (cross-sectional analysis within an RCT), or with
the characteristics of the instrument itself. Other scree-
ning instruments are available for anxiety disorders that
have been tested in primary care and that showed
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Disorder-7 item scale (GAD-7) [38], the Hospital Anxiety
and Depression Scale [39], and the Four Dimensional
Symptom Questionnaire (4DSQ) [40]. The GAD-7, deve-
loped by the same research group that produced the
PHQ, may be more accurate than the PHQ in detecting
anxiety disorders [41]. This may be in part due to the fact
that the GAD-7 contains three items that differ from the
PHQ items and, moreover, because it yields a continuous
score that allows a selection of an optimal cutpoint. While
the original study showed good AUCs for the GAD-7 in
detecting anxiety disorders other than GAD, differing
results from a recent study [37] suggest that the perfor-
mance of the GAD-7 for anxiety disorders other than
GAD needs further research. As there is no direct com-
parison available between the GAD-7 and the PHQ, there
is no decisive information yet on which scale performs
best. The HADS has also shown adequate characteristics
in primary care patients [11,12]. However, just as with the
GAD-7, limited information is available about the prac-
tical value of the HADS in high-risk primary care patients
or GP-identified patients. One study comparing the
HADS and the 4DSQ in GP-identified patients has shown
areas under the curve [10] similar to the area under the
curve of 77% found in our study.
Implications for future research and practice
The high prevalence of anxiety disorders (39%) in the
high-risk sample suggests that selecting patients from the
EMR on the basis of psychological symptoms, social prob-
lems or physical symptoms related to anxiety disorders
might be a successful method for selective screening in
primary care. This may be especially relevant for patients
presenting with physical symptoms as it is difficult for
GPs to recognise anxiety disorders in these patients [42].
The finding that the use of the two screening questions of
the PHQ resulted in the best performance is positive, as
this makes the screening procedure short. However, when
implementing a selective screening procedure, it needs to
be followed by a structured approach of further clinical
diagnostic procedures and evidence-based treatment, as
recommended in clinical guidelines [6]. Therefore, low-
intensity interventions need to be available in primary care
to be able to treat a large number of patients [43]. Only
then will selective screening be an effective way of impro-
ving management of anxiety disorders. With regard to
GPs who referred patients to this study, it is noteworthy
that they did correctly suspect the presence of an anxiety
disorder in 80% of the cases. However, the number of
patients that GPs identified varied widely (from 0 to 17).
Efforts to improve detection of anxiety disorders may thus
be aimed at GPs with a low recognition rate of anxiety dis-
orders. Furthermore, it may be worthwhile to prompt GPs
to investigate the presence of an anxiety disorder with thePHQ in patients with less obvious anxiety symptoms. We
recommend that future diagnostic studies should pay
attention to the practical purposes of screening instru-
ments, to help informing primary care on the best way to
use these instruments. Additional research is also neces-
sary to investigate the most effective method for screening
for anxiety disorders in terms of higher treatment rates
[44,45] and improved patient outcomes [14].
Conclusions
The results of this study show that the two screening
questions of the PHQ form a suitable instrument for
screening for anxiety disorders in high-risk primary care
patients. Although GPs may use the official algorithm of
the PHQ in adjunct to their clinical diagnosis, they are
not advised to use the PHQ for the purpose of ruling
out the presence of an anxiety disorder. Following this
study, research should focus on the effectiveness of
selective screening for anxiety disorders in primary care
and on strategies to improve the recognition of anxiety
disorders by GPs with a low recognition rate.
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